Product Description
| Cat Number | EP-040 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | EGFRvIII derived epitope |
| Modification | None |
| Purity | >95% by hplc |
| Biomarker Target | Epitopes,Receptor tyrosine kinases |
| Sequence Three Letter Code | H-Leu-Glu-Glu-Lys-Lys-Gly-Asn-Tyr-Val-OH |
| Molecular Formula | C48H78N12O16 |
| Sl Sequence | LEEKKGNYV |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Moscatello et al (1997) A naturally occurring mutant human epidermal growth factor receptor as a target for peptide vaccine immunotherapy of tumors. Cancer Res. 57(8) 1419 PMID: 9108438Wu et al (2006) Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas. J Neurooncol. 76(1) 23 PMID: 16155724Choi et al (2022) Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model. BMC Cancer 22(1) 986 PMID: 36109710 Related areasAll epitopes >All cancer research categories >All immunology research categories > |
| Note | The product is for research use only |
Share Item: